
🧬 Redefining Biotech: Building Enduring Value Beyond Acquisition | Rabia Khan (Part 4/4)
"If you are that person, if you feel like you can't find your box and you're off doing these random things that no one else seems to find interesting, it's okay. Embrace it. It's who you are and it's going to be your superpower someday." In this episode of The Biotech Startups Podcast, host Jon Chee sits down with Rabia Khan, founder and CEO of Serna Bio, to discuss her journey from Sensyne Health to building a data-driven biotech company pioneering RNA-targeted drug discovery. Rabia shares how she overcame scientific and operational hurdles, navigated contract research limitations, and boldly moved Serna Bio from the UK to San Francisco. She also reveals her intentional approach to company culture, frugality, and long-term impact—emphasizing her vision to create a biotech business built for enduring innovation, not just acquisition.
The Biotech Startups Podcast · Excedr
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
- Breaking Industry Molds: Serna Bio puts RNA at the center, challenging protein-focused norms.
- Data-First Biotech: Massive RNA datasets drive unique insights.
- Lean Operations & Frugality: Every dollar fuels innovation.
- Company Building for Endurance: Built for long-term value, not quick exits.
- Authentic Leadership: Bold, authentic leadership for lasting impact.
Timestamps: